Literature DB >> 18772020

VEGF receptor signal transduction.

Xiujuan Li1, Lena Claesson-Welsh, Masabumi Shibuya.   

Abstract

Signal transduction by vascular endothelial growth factors (VEGFs) through their cognate VEGF receptor tyrosine kinases follows the consensus scheme for receptor tyrosine kinases. Thus, binding of ligand induces receptor dimerization and activation of the tyrosine kinase through transphosphorylation between receptor molecules, leading to initiation of intracellular signal transduction pathways. Certain signal transduction pathways are shared with most, if not all, receptor tyrosine kinases, whereas some may be unique (e.g., transduced only by VEGF receptors). Indications that such unique signaling pathways may be discerned only when VEGF receptors are expressed in their proper context (i.e., in endothelial cells of microcapillary origin). In this chapter, we describe a number of methods for the study of signal transduction in endothelial cells. We describe how to isolate and examine endothelial cell lines. We also describe the embryoid body model representing vasculogenesis and angiogenesis, the procedure for subcutaneous Matrigel plugs, and, finally, how to construct gene-targeted mouse models. We emphasize the need for validation of in vitro data in more complex models, where endothelial cells reside in their proper three-dimensional context.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772020     DOI: 10.1016/S0076-6879(08)02013-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  17 in total

Review 1.  How blood vessel networks are made and measured.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity.

Authors:  Errol Wijelath; Mayumi Namekata; Jacqueline Murray; Mai Furuyashiki; Siyuan Zhang; Daniel Coan; Masahiro Wakao; Robert B Harris; Yasuo Suda; Lianchun Wang; Michael Sobel
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

3.  The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.

Authors:  You-Bing Zheng; Mei-Xiao Zhan; Wei Zhao; Bing Liu; Jian-Wen Huang; Xu He; Si-Rui Fu; Yan Zhao; Yong Li; Bao-Shan Hu; Li-Gong Lu
Journal:  Med Oncol       Date:  2014-09-03       Impact factor: 3.064

4.  A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression.

Authors:  Elena Geretti; Laurens A van Meeteren; Akio Shimizu; Andrew C Dudley; Lena Claesson-Welsh; Michael Klagsbrun
Journal:  Mol Cancer Res       Date:  2010-07-22       Impact factor: 5.852

5.  VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.

Authors:  Kan V Lu; Jeffrey P Chang; Christine A Parachoniak; Melissa M Pandika; Manish K Aghi; David Meyronet; Nadezda Isachenko; Shaun D Fouse; Joanna J Phillips; David A Cheresh; Morag Park; Gabriele Bergers
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

6.  VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.

Authors:  Ingrid Nilsson; Fuad Bahram; Xiujuan Li; Laura Gualandi; Sina Koch; Malin Jarvius; Ola Söderberg; Andrey Anisimov; Ivana Kholová; Bronislaw Pytowski; Megan Baldwin; Seppo Ylä-Herttuala; Kari Alitalo; Johan Kreuger; Lena Claesson-Welsh
Journal:  EMBO J       Date:  2010-03-11       Impact factor: 11.598

7.  Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.

Authors:  Ujala Rana; Zhong Liu; Suresh N Kumar; Baofeng Zhao; Wenquan Hu; Michelle Bordas; Stephanie Cossette; Sara Szabo; Jamie Foeckler; Hartmut Weiler; Magdalena Chrzanowska-Wodnicka; Mary L Holtz; Ravindra P Misra; Valerie Salato; Paula E North; Ramani Ramchandran; Qing Robert Miao
Journal:  Dev Biol       Date:  2015-12-31       Impact factor: 3.582

8.  Local guidance of emerging vessel sprouts requires soluble Flt-1.

Authors:  John C Chappell; Sarah M Taylor; Napoleone Ferrara; Victoria L Bautch
Journal:  Dev Cell       Date:  2009-09       Impact factor: 12.270

9.  Epoxyeicosanoids promote organ and tissue regeneration.

Authors:  Dipak Panigrahy; Brian T Kalish; Sui Huang; Diane R Bielenberg; Hau D Le; Jun Yang; Matthew L Edin; Craig R Lee; Ofra Benny; Dayna K Mudge; Catherine E Butterfield; Akiko Mammoto; Tadanori Mammoto; Bora Inceoglu; Roger L Jenkins; Mary A Simpson; Tomoshige Akino; Fred B Lih; Kenneth B Tomer; Donald E Ingber; Bruce D Hammock; John R Falck; Vijaya L Manthati; Arja Kaipainen; Patricia A D'Amore; Mark Puder; Darryl C Zeldin; Mark W Kieran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

10.  GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Authors:  Silvia Coma; Marc Allard-Ratick; Tomoshige Akino; Laurens A van Meeteren; Akiko Mammoto; Michael Klagsbrun
Journal:  Angiogenesis       Date:  2013-07-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.